Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VELIPARIB vs VEMURAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VELIPARIB vs VEMURAFENIB: Safety Overview

Metric VELIPARIB VEMURAFENIB
Total FAERS Reports 391 8,562
Deaths Reported 43 1,040
Death Rate 11.0% 12.1%
Hospitalizations 222 2,368
Average Patient Age 57.9 yrs 58.1 yrs
% Female Patients 92.3% 45.7%
FDA Approval Date N/A Aug 17, 2011
Manufacturer N/A Genentech, Inc.
Route N/A ORAL
Marketing Status N/A Prescription